Details for New Drug Application (NDA): 019906
✉ Email this page to a colleague
NDA 019906 describes ANAFRANIL, which is a drug marketed by Specgx Llc and is included in one NDA. It is available from one supplier. Additional details are available on the ANAFRANIL profile page.
The generic ingredient in ANAFRANIL is clomipramine hydrochloride. There are eleven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the clomipramine hydrochloride profile page.
The generic ingredient in ANAFRANIL is clomipramine hydrochloride. There are eleven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the clomipramine hydrochloride profile page.
Summary for 019906
| Tradename: | ANAFRANIL |
| Applicant: | Specgx Llc |
| Ingredient: | clomipramine hydrochloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 019906
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ANAFRANIL | clomipramine hydrochloride | CAPSULE;ORAL | 019906 | NDA | SpecGx LLC | 0406-8806 | 0406-8806-01 | 100 CAPSULE in 1 BOTTLE (0406-8806-01) |
| ANAFRANIL | clomipramine hydrochloride | CAPSULE;ORAL | 019906 | NDA | SpecGx LLC | 0406-8807 | 0406-8807-01 | 100 CAPSULE in 1 BOTTLE (0406-8807-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 25MG | ||||
| Approval Date: | Dec 29, 1989 | TE: | AB | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
| Approval Date: | Dec 29, 1989 | TE: | AB | RLD: | Yes | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 75MG | ||||
| Approval Date: | Dec 29, 1989 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
